Company Filing History:
1 out of 15 
1 out of 3 Years Active: 2019-2022
Title: J H Frederik Falkenburg: Innovator in Hematological Treatments
Introduction
J H Frederik Falkenburg is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of hematology through his innovative patents. With a total of two patents to his name, Falkenburg's work focuses on advancing treatments for hematological malignancies.
Latest Patents
Falkenburg's latest patents include groundbreaking technologies. The first patent addresses the treatment of hematological malignancies, providing novel nucleic acid sequences, vectors, modified cells, peptides, and pharmaceutical compositions. These innovations are particularly useful for treating human subjects with NPM1 positive hematological malignancies. The second patent involves T cell receptors directed against the Bob1 antigen. This technology relates to compositions and methods for inducing an immune response against Bob1, which can be utilized in treating hyperproliferative diseases.
Career Highlights
Throughout his career, Falkenburg has been associated with prestigious institutions. He has worked at Leiden University Medical Center and Academisch Ziekenhuis Leiden, known as Leids Universitair Medisch Centrum. His work in these institutions has allowed him to contribute significantly to medical research and innovation.
Collaborations
Falkenburg has collaborated with esteemed colleagues, including Mirjam H M Heemskerk and Marieke Griffioen. These collaborations have further enhanced his research and development efforts in the field of hematology.
Conclusion
J H Frederik Falkenburg is a prominent inventor whose work has the potential to transform treatments for hematological malignancies. His innovative patents and collaborations reflect his commitment to advancing medical science.